The European Calcified Tissue Society (ECTS) is a non-for profit organisation in Europe for researchers and clinicians working in the field of calcified tissues and related fields. Our mission is to promote excellence in research into the field of calcified tissues within Europe and beyond, and to ensure the findings are disseminated to enable benefit to patients with metabolic bone disease.  ECTS represents more than 600 members at all stages of career and has a network of over 30 national and international societies.  More information at

ECTS expertise and fully support will help BioMed Alliance to provide recommendations for policy and decision makers on facilitating and mproving biomedical research in Europe.  

You are invited  attend the event: ‘Maximise the value and the impact of health research in Europe’ organised by the BioMed Alliance and chaired by Paul Rübig, MEP & 1st Vice-Chair STOA, to be held at Square de Meeûs, 29, Brussels, on Wednesday April 25 from 10h30 – 12h30.

High level speakers include Annika Nowak, member of the cabinet of Commissioner Andriukaitis, Line Matthiessen, Acting Director, Health Directorate, European Commission, DG Research and Innovation and Karin Sipido, Chair, Scientific Panel for Health, European Commission. Discussions will focus on the upcoming Framework Programme 9, and will highlight the impact and societal value of health research. Speakers from across different biomedical sectors will address policies issues such as EU funding, EU research projects and collaborations, synergies between national and EU research programmes and long term vision and strategies.

For additional information and registration please contact Loredana Simulescu, BioMed Alliance policy officer. Tel: 32 (0) 22741073, This email address is being protected from spambots. You need JavaScript enabled to view it.

You can find the programe here


Read the interview with Prof. Axel Pries – President of the BioMed Alliance and Prof. Gunhild Waldemar – member of the BioMed Alliance Board of Directors. Read the article here.

BioMed Alliance Member Organisations elected him at the General Assembly on 8 November 2017  for a two-year period.

Download the PDF

BioMed Alliance Board of Director Ulrich Jaeger argues that EU funding is crucial in allowing medical researchers across member states to collaborate in the development of new treatments. In Framework Programme 9, processes must be optimised and the budget boosted - to deliver for patients and the economy.  Read the article here

Experts discuss the FEAM-BioMed Alliance Paper in Open Access Government. The FEAM-BioMed Alliance Paper outlines how the next EU Framework Programme can further support biomedical research in Europe. Read the article here.

The European Crohn's and Colitis Organisation (ECCO), founded in 2001 to improve the care of patients with inflammatory bowel disease (IBD) in Europe, is now the largest forum for specialists in IBD in the world. It is a non-profit association, which successfully expanded from an organisation comprising 14 Country Members to an association assembling 36 member states of the Council of Europe and facilitating collaborations beyond Europe's borders. You can find more info here:

Download the PDF

Download the PDF

Fore more info click here

See the newsletter online

Download the PDF

Programme and agenda

See the newsletter online

See the newsletter online

BioMed Alliance Policy Officer: 8th of November (9:00-12:30), at BioMed Alliance office

General Assembly 2016: 9th of November (9:00 – 16:00), at the Sofitel Le Louise Hotel, Brussels.

An official dinner will be organized on 8th of November (20:00 – 22:00) at the same hotel.

Strategic meeting with Presidents of BioMed Alliance member societies: 29th of November, at BioMed Alliance office.

BioMed Alliance Event in the European Parliament: 29th of November (12:00-14:00)

Download the document